New study suggests that Novo Nordisk’s Ozempic may lower dementia risk and nicotine use. Meanwhile, UnitedHealth Group’s cyberattack woes…
published last week, which found that Ozempic could lower the risk of dementia and a range of other mental problems compared with other existing treatments for patients with diabetes. What's more, researchers found that Ozempic cut nicotine dependence in those patients.
The study relied on medical records from more than 100,000 U.S. diabetes patients, including more than 20,000 who were prescribed semaglutide between December 2017 and May 2021.Eli Lilly Feeling out of the loop? We'll catch you up on the Chicago news you need to know. Sign up for the weeklyAfter a year, patients who took Ozempic had a 48% lower risk of developing dementia than those on Januvia. The risk in Ozempic patients was also 37% lower than those who took Glucotrol and 9% lower than those on Jardiance.Patients who took Ozempic also saw an 18% reduction in nicotine dependence compared to those on Januvia.
on Tuesday that beat analysts' estimates on the top and bottom lines, but it increased its forecast for the expected per-share impact of the Change Healthcare cyberattack.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine useNew study suggests that Novo Nordisk’s Ozempic may lower dementia risk and nicotine use. Meanwhile, UnitedHealth Group’s cyberattack woes…
Read more »
Diabetes patients using Ozempic, other treatments instead of insulin have lower cancer risk, study findsType 2 diabetes patients on GLP-1 treatments, including Ozempic, have a lower risk of 10 types of obesity-related cancers compared to those on insulin, according to a new study.
Read more »
Ozempic's popularity leads to shortages for people with Type 2 diabetesDrugs like Ozempic, Wegovy and Mounjaro are in such high demand that many patients with Type 2 diabetes can't get them when they need them.
Read more »
Ozempic's popularity leads to shortages for people with Type 2 diabetesDrugs like Ozempic, Wegovy and Mounjaro are in such high demand that many patients with Type 2 diabetes can't get them when they need them.
Read more »
‘Ozempic babies’: Popular diabetes drugs linked to surprise pregnanciesScientists believe that we are 'in a data-free zone' with respect to fertility and GLP-1 agonists like Ozempic and Wegovy.
Read more »
‘Healthy’ kids’ foods that are not healthyOne in five kids and adolescents in the U.S. is obese and it’s considered a serious public health problem.
Read more »